Physicians Realty Trust
NYSE:DOC

Watchlist Manager
Physicians Realty Trust Logo
Physicians Realty Trust
NYSE:DOC
Watchlist
Price: 20.78 USD 0.39% Market Closed
Market Cap: 14.6B USD

Physicians Realty Trust
Investor Relations

In the intricate web of healthcare and real estate, Physicians Realty Trust weaves a unique narrative. Born in 2013, this real estate investment trust (REIT) has carved a niche as a diligent custodian of healthcare facilities across the United States. The company's primary mission is to acquire, develop, and manage high-quality healthcare properties, focusing predominantly on medical office buildings. These are not just any buildings; they're crucial infrastructural elements that serve as the points of intersection between surgery centers, clinical operations, and diagnostic services, all of which are vital to the functioning of modern healthcare systems. By entering into long-term lease agreements with a diverse range of healthcare providers, Physicians Realty Trust ensures a steady income stream, tethering its fortunes to the robust demand for healthcare services.

Revenue for Physicians Realty Trust flows primarily from these leasing arrangements, crafting its financial stability upon the bedrock of reliable occupancy rates and strategic location choices. The company's portfolio is designed to meet the evolving needs of healthcare providers, offering spaces that are essential for physicians to deliver quality patient care. Beyond the typical landlord-tenant dynamic, Physicians Realty Trust partners with healthcare institutions to support their growth and operational efficiency, engendering a symbiotic relationship. This emphasis on collaboration and adaptability allows the trust to not just collect rents, but to actively contribute to the healthcare ecosystem, thereby bolstering its own value proposition in the market. Through this model, Physicians Realty Trust thrives on not just the physical spaces it owns, but on the essential services its tenants provide, anchoring its financial success in the health of both its properties and the communities they serve.

Show more
Loading

Earnings Calls

2024 Q4
Nov 6, 2024
Show Transcript
Previous
Next
Johnson Controls sees strong growth and margins heading into 2025.
2024 Q4
Nov 6, 2024

In the fourth quarter, Johnson Controls reported a robust 10% organic revenue growth and a 260 basis points increase in segment margin to 18.6%. Annual adjusted EPS rose 22% to $1.28, exceeding guidance. The company expects 2025 adjusted EPS of $3.40 to $3.50. A record backlog of $13.1 billion reflects strong demand in verticals like data centers. For Q1 2025, organic sales growth is projected in the mid-single digits, with expected margin expansion of over 100 basis points. Additionally, a restructuring plan aims to generate $500 million in annual savings over three years, enhancing operational efficiency.

Show Full Analysis

Management

Mr. Scott M. Brinker
President, CEO & Director
No Bio Available
Mr. Scott R. Bohn
Chief Development Officer & Head of Lab
No Bio Available
Mr. Adam G. Mabry
Chief Investment Officer
No Bio Available
Mr. Shawn G. Johnston
Executive VP & Chief Accounting Officer
No Bio Available
Mr. Andrew Johns CFA
Senior Vice President of Investor Relations
No Bio Available
Mr. Jeffrey H. Miller
General Counsel
No Bio Available
Ms. Lisa A. Alonso
Executive VP & Chief Human Resources Officer
No Bio Available
Mr. James A. Croy
Senior Vice President of Leasing - Outpatient Medical
No Bio Available
Mr. Antonio Acevedo
Senior Vice President of Asset Management - Outpatient Medical
No Bio Available
Mr. Jameson J. Bennett
Senior Vice President of Outpatient Medical Finance
No Bio Available

Contacts

Address
WISCONSIN
Milwaukee
309 N Water St Ste 500
Contacts
+14143675600.0
www.docreit.com